This protocol is judged by an institutional assessment board, an unbiased team that reviews any clinical trials involving humans. If a study requires a Routine I drug, as soon as the board approves the protocol as moral, the researchers really have to submit an application for an investigational new drug (IND) selection within the FDA.This text fe